Home/Filings/4/0001613377-18-000012
4//SEC Filing

PASCALE ADAM 4

Accession 0001613377-18-000012

CIK 0000946644other

Filed

Jul 18, 8:00 PM ET

Accepted

Jul 19, 12:50 PM ET

Size

5.3 KB

Accession

0001613377-18-000012

Insider Transaction Report

Form 4
Period: 2018-07-18
Pascale Adam
Chief Accounting Officer
Transactions
  • Award

    Options to buy Common Stock

    2018-07-18+53,76353,763 total
    Exercise: $0.31From: 2018-07-18Exp: 2028-07-18Common Stock (53,763 underlying)
Footnotes (1)
  • [F1]This option is being issued to senior management in exchange for a voluntary 40% deferral in salary.

Issuer

HEMISPHERX BIOPHARMA INC

CIK 0000946644

Entity typeother

Related Parties

1
  • filerCIK 0001613377

Filing Metadata

Form type
4
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 12:50 PM ET
Size
5.3 KB